4
Changes in Ownership
InMed Pharmaceuticals Inc. Filed Acc 0001213900-22-080968
Options or other derivatives
- Sr. VP, Pre-Clinical Res/Dev acquired 4,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 2022-12-16 | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,878 | D | ||
Loading xslF345X03/ownership.xml…